HARMONY BIOSCIENCES TO PARTICIPATE IN UPCOMING INVESTOR CONFERENCES
HARMONY BIOSCIENCES TO PARTICIPATE IN UPCOMING INVESTOR CONFERENCES
A webcast of the fireside chat will be available on the investor page of Harmony's website at .PLYMOUTH MEETING, Pa., Nov. 21, 2024 /PRNewswire/ -- Harmony Biosciences Holdings, Inc. (Nasdaq: HRMY), today announced that Harmony's management team will participate in the following upcoming investor conferences:
2024年11月21日，賓夕法尼亞州普利茅斯會議，和睦生物科技控股公司（納斯達克股票代碼：HRMY）今天宣佈和睦的管理團隊將參加以下即將舉行的投資者會議：
Citi's 2024 Global Healthcare Conference
花旗銀行2024年全球醫療保健會議
- Location: Miami
- Tuesday, December 3, 2024
- 地點：邁阿密
- 2024年12月3日星期二
Piper Sandler 36th Annual Healthcare Conference
派傑投資第36屆醫療保健年會
- Location: New York City
- Fireside Chat: Wednesday, December 4, 2024, at 8:30 a.m., ET
- 地點：紐約市
- 爐邊訪談：2024年12月4日，東部時間上午8:30
A webcast of the fireside chat will be available on the investor page of Harmony's website at .
爐邊訪談的網絡直播將在和睦網站的投資者頁面上提供。 .
About Harmony Biosciences
Harmony Biosciences is a pharmaceutical company dedicated to developing and commercializing innovative therapies for patients with rare neurological diseases who have unmet medical needs. Driven by novel science, visionary thinking, and a commitment to those who feel overlooked, Harmony Biosciences is nurturing a future full of therapeutic possibilities that may enable patients with rare neurological diseases to truly thrive. Established by Paragon Biosciences, LLC, in 2017 and headquartered in Plymouth Meeting, PA, we believe that when empathy and innovation meet, a better future can begin; a vision evident in the therapeutic innovations we advance, the culture we cultivate, and the community programs we foster. For more information, please visit .
Harmony生物科學
Harmony Biosciences是一家致力於爲患有罕見神經系統疾病且醫療需求未被滿足的患者開發和推廣創新療法的藥品公司。在新穎的科學、有遠見的思維和對感到被忽視的人的承諾的驅動下，Harmony Biosciences正在孕育一個充滿治療可能性的未來，這可能使患有罕見神經系統疾病的患者真正茁壯成長。由Paragon Biosciences, LLC於2017年成立，總部位於賓夕法尼亞州普利茅斯會議，我們相信當同理心和創新相遇時，更美好的未來可以開始；這一願景體現在我們推進的治療創新、我們培育的文化和我們促進的社區項目中。欲了解更多信息，請訪問 .
Harmony Biosciences Investor Contact:
Brennan Doyle
484-539-9700
[email protected]
Harmony生物科學投資人聯繫方式：
Brennan Doyle
484-539-9700
[email protected]
Harmony Biosciences Media Contact:
Cate McCanless
202-641-6086
[email protected]
Harmony生物科學媒體聯繫方式：
凱特·麥坎萊斯（Cate McCanless）
202-641-6086
[email protected]
SOURCE Harmony Biosciences
消息來源：Harmony生物科學
